tiprankstipranks
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Canadian Market
CRDL
Cardiol Therapeutics
RESEARCH TOOLSreports

Cardiol Therapeutics (CRDL) Income Statement

219 Followers

Cardiol Therapeutics Income Statement

Last quarter (Q4 2025), Cardiol Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Cardiol Therapeutics's net income was C$-7.21M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 78.76K
Gross Profit
C$ 0.00C$ -373.11KC$ -248.35KC$ -219.91KC$ 78.76K
Operating Expenses
C$ 34.32MC$ 39.90MC$ 29.54MC$ 41.34MC$ 38.74M
Depreciation and Amortization
C$ 101.98KC$ 373.11KC$ 248.35KC$ 219.91KC$ 220.42K
EBITDA
C$ -34.21MC$ -36.30MC$ -27.88MC$ -30.71MC$ -38.44M
Operating Income
C$ -34.32MC$ -40.28MC$ -29.79MC$ -50.34MC$ -45.47M
Other Income/Expenses
C$ 497.42KC$ 3.60MC$ 1.66MC$ 10.41MC$ 7.03M
Pretax Income
C$ -33.82MC$ -36.68MC$ -28.13MC$ -30.93MC$ -31.64M
Net Income
C$ -33.82MC$ -36.68MC$ -28.13MC$ -11.52MC$ -24.72M
Per Share Metrics
Basic EPS
C$ -0.39C$ -0.51C$ -0.44C$ -0.18C$ -0.57
Diluted EPS
C$ -0.39C$ -0.51C$ -0.44C$ -0.18C$ -0.57
Weighted Average Shares Outstanding
 86.99M 71.57M 64.46M 62.51M 43.22M
Weighted Average Shares Outstanding (Diluted)
 86.99M 71.57M 64.46M 62.51M 43.22M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History